Article
Molecular and Clinicopathologic Impact of GNAS Variants Across Solid Tumors.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology - 10 Nov 2024
Johannet Paul, Abdelfattah Somer, Wilde Callahan, Patel Shrey, Walch Henry, Rousseau Benoit, Argiles Guillem, Artz Oliver, Patel Miteshkumar, Arfe Andrea, Cercek Andrea, Yaeger Rona, Ganesh Karuna, Schultz Nikolaus, Diaz Luis A, Foote Michael B
Abstract excerpt
PURPOSE: The molecular drivers underlying mucinous tumor pathogenicity are poorly understood. GNAS mutations predict metastatic burden and treatment resistance in mucinous appendiceal adenocarcinoma. We investigated the pan-cancer clinicopathologic relevance of GNAS variants. METHODS: We assessed 58,043 patients with Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
